No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carboplatin / administration & dosage
-
Carcinoma, Neuroendocrine / drug therapy*
-
Carcinoma, Neuroendocrine / genetics
-
Carcinoma, Neuroendocrine / metabolism
-
Etoposide / administration & dosage
-
Female
-
Gallbladder / drug effects*
-
Gallbladder / metabolism
-
Gallbladder / pathology
-
Humans
-
Ipilimumab / administration & dosage
-
Ki-67 Antigen / analysis
-
Middle Aged
-
Mutation
-
Neoplasm Grading
-
Neoplasm Metastasis
-
Nivolumab / administration & dosage
-
Retinoblastoma Binding Proteins / genetics
-
Treatment Outcome
-
Tumor Suppressor Protein p53 / genetics
-
Ubiquitin-Protein Ligases / genetics
Substances
-
Ipilimumab
-
Ki-67 Antigen
-
RB1 protein, human
-
Retinoblastoma Binding Proteins
-
Tumor Suppressor Protein p53
-
Nivolumab
-
Etoposide
-
Carboplatin
-
Ubiquitin-Protein Ligases